Poor clinical outcomes and immunoevasive contexture in gastric cancer patients bearing p16 high phenotype.
2026-03-15, Cancer (10.1002/cncr.70363) (online)Hongyong He, Ruochen Li, Jieti Wang, Jiejie Xu, Yun Gu, Ziqiu Zhang, Zhen Ling, Chao Lin, Hao Liu, and Fei Shao (?)
The aberrant p16 expression has been identified in gastric cancer (GC). However, the staining pattern of p16 and its associations with clinical outcomes and immune contexture remains obscure.
This article has not yet been included in any curations.



Comments
There are no comments on this article yet.
You need to login or register to comment.